StockData

Orchestra BioMed Holdings, Inc. (OBIO) stock

OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$7.12−0.13 (-1.79%)

Close on Nov 16, 2026Market cap $427.95MP/E –Yield –

Orchestra BioMed cash

Cash and short-term investments held at the end of each period.

Orchestra BioMed's cash was $109.96M at Jun 30, 2026. For fiscal 2025 it was $106.51M, up 59.4% from the year before. The highest annual figure on record is $106.51M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$106.51M+59.4%
FY2024Dec 31, 2024$66.81M-23.7%
FY2023Dec 31, 2023$87.53M+4.6%
FY2022Dec 31, 2022$83.70M+742.2%
FY2021Dec 31, 2021$9.94M+390.3%
FY2020Dec 31, 2020$2.03M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$109.96M+224.1%
Q1 FY2026Mar 31, 2026$94.40M+89.2%
Q4 FY2025Dec 31, 2025$106.51M+59.4%
Q3 FY2025Sep 30, 2025$95.82M+43.2%
Q2 FY2025Jun 30, 2025$33.92M-48.0%
Q1 FY2025Mar 31, 2025$49.88M-33.5%
Q4 FY2024Dec 31, 2024$66.81M-23.7%
Q3 FY2024Sep 30, 2024$66.93M-38.3%
Q2 FY2024Jun 30, 2024$65.18M-44.6%
Q1 FY2024Mar 31, 2024$75.02M-41.0%
Q4 FY2023Dec 31, 2023$87.53M+4.6%
Q3 FY2023Sep 30, 2023$108.49M+11.8%
Q2 FY2023Jun 30, 2023$117.70M+10.0%
Q1 FY2023Mar 31, 2023$127.13M+333.4%
Q4 FY2022Dec 31, 2022$83.70M+742.2%
Q3 FY2022Sep 30, 2022$97.00M+5339.1%
Q2 FY2022Jun 30, 2022$106.97M+5496.9%
Q1 FY2022Mar 31, 2022$29.33M+1403.8%
Q4 FY2021Dec 31, 2021$9.94M+390.3%
Q3 FY2021Sep 30, 2021$1.78M-12.5%
Q2 FY2021Jun 30, 2021$1.91M+886.8%
Q1 FY2021Mar 31, 2021$1.95M–
Q4 FY2020Dec 31, 2020$2.03M–
Q3 FY2020Sep 30, 2020$2.04M–
Q2 FY2020Jun 30, 2020$193.69K–

More Orchestra BioMed figures

See a number that looks wrong?